NDC 14783-142 Bioresist Reinforcing Effect Face Moisturizer Spf 30
Avobenzone, Octisalate, Octocrylene Cream Topical

Product Information

Product Code14783-142
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Bioresist Reinforcing Effect Face Moisturizer Spf 30
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Avobenzone, Octisalate, Octocrylene
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Human Otc Drug
Dosage FormCream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s) What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Ventura International Ltd
Labeler Code14783
FDA Application Number What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
part352
Marketing Category What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
01-01-2020
Listing Expiration Date What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
12-31-2022
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
N
NDC Code Structure

Usage Information


Product Packages

NDC 14783-142-01

Package Description: 30 mL in 1 BOTTLE

NDC 14783-142-02

Package Description: 5 mL in 1 BOTTLE

Product Details

Bioresist Reinforcing Effect Face Moisturizer Spf 30 is a human over the counter drug product labeled by Ventura International Ltd. The generic name of Bioresist Reinforcing Effect Face Moisturizer Spf 30 is avobenzone, octisalate, octocrylene. The product's dosage form is cream and is administered via topical form.


What are Bioresist Reinforcing Effect Face Moisturizer Spf 30 Active Ingredients?

The following is the list of active ingredients in this product. An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.


Inactive Ingredient(s)

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • MYRISTYL ALCOHOL (UNII: V42034O9PU)
  • ACACIA (UNII: 5C5403N26O)
  • YEAST, UNSPECIFIED (UNII: 3NY3SM6B8U)
  • LIMONENE, (+)- (UNII: GFD7C86Q1W)
  • LINALOOL, (+/-)- (UNII: D81QY6I88E)
  • .BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
  • STEARIC ACID (UNII: 4ELV7Z65AP)
  • SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
  • LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
  • CAPRYLYL GLYCOL (UNII: 00YIU5438U)
  • BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)
  • DOCOSANOL (UNII: 9G1OE216XY)
  • GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
  • COCO-CAPRYLATE (UNII: 4828G836N6)
  • WATER (UNII: 059QF0KO0R)
  • ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)
  • ETHYLHEXYL METHOXYCRYLENE (UNII: S3KFG6Q5X8)
  • ARGININE (UNII: 94ZLA3W45F)
  • BUTYLPHENYL METHYLPROPIONAL (UNII: T7540GJV69)
  • PYRROLIDONE CARBOXYLIC ACID (UNII: 6VT1YZM21H)
  • POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)
  • PALMITIC ACID (UNII: 2V16EO95H1)
  • BETASIZOFIRAN (UNII: 2X51AD1X3T)
  • EDETIC ACID (UNII: 9G34HU7RV0)
  • PULLULAN (UNII: 8ZQ0AYU1TT)
  • PHYTATE SODIUM (UNII: 88496G1ERL)
  • PHENOXYETHANOL (UNII: HIE492ZZ3T)
  • PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)
  • LAURYL ALCOHOL (UNII: 178A96NLP2)
  • BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
  • SQUALANE (UNII: GW89575KF9)
  • 2',3'-DIHYDROXYACETOPHENONE (UNII: 65328I5OQP)
  • XANTHAN GUM (UNII: TTV12P4NEE)
  • 1,2-HEXANEDIOL (UNII: TR046Y3K1G)
  • CETYL ALCOHOL (UNII: 936JST6JCN)


* Please review the disclaimer below.

Bioresist Reinforcing Effect Face Moisturizer Spf 30 Labeling and Warnings

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



* Please review the disclaimer below.